Company news

Share this article:
Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Under the terms of the deal, Standard Chem. & Pharm. has the exclusive development and manufacturing rights and Cypress Pharmaceutical, Inc. has exclusive US marketing rights of generic drug products. Other financial terms of the agreement have not been disclosed.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.